Medicus Pharma Ltd.(MDCX)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Medicus Pharma Ltd. (MDCX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. MDCX is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of MDCX by reported 13-F value include Interchange Capital Partners, JANE STREET GROUP, XTX Topco Ltd, based on the most recent SEC filings. MDCX trades on the Nasdaq exchange and files with the SEC under CIK 1997296. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MDCX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Medicus Pharma Ltd. directly from SEC EDGAR.

Net Income

$-11.6M

Institutions holding MDCX

Institutional investors reporting a position in Medicus Pharma Ltd. on SEC Form 13F.
InstitutionSharesValueReported
Interchange Capital Partners1,586,871$718.4K2026-06-30
JANE STREET GROUP333,673$148.9K2026-06-30
XTX Topco Ltd243,362$108.6K2026-06-30
Sterling Investment Advisors, Ltd.100,000$44.6K2026-06-30
ARMISTICE CAPITAL60,600$39.4K2026-06-30
COMMONWEALTH EQUITY SERVICES52,643$23.5K2026-06-30
May Hill Capital50,622$22.6K2026-06-30
Anson Funds Management42,400$18.9K2026-06-30
SUSQUEHANNA INTERNATIONAL GROUP, LLP31,462$14.0K2026-06-30
STIFEL FINANCIAL30,000$13.4K2026-06-30
MDCX

Medicus Pharma Ltd.

MDCX
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Net Income

Q2 2026
EDGAR

$-11.62M

EPS (Diluted)

Q2 2026
EDGAR

$-0.21

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…